Studies related to Menopause and Dehydroepiandrosterone (DHEA)

Long-term Low-dose Dehydroepiandrosterone Oral Supplementation In Early And Late Postmenopausal Women Modulates Endocrine Parameters And Synthesis Of Neuroactive Steroids

Effect Decrease
Trial Design Non-controlled trial
Trial Length 6+ Months
Number of Subjects 20
Sex Female
Age Range 45-64
Body Types Overweight
Notes for this study:
25mg of DHEA over 12 months was able to increase all steroid hormones in the serum, including the neurosteroids allopregnanolone and beta-endorphin. SHBG also decreased alongside cortisol, and overall menopausal symptoms in these women was decreased.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.